These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1924423)

  • 1. Immunotherapy of gram-negative septicemia.
    van Deventer SJ
    Prog Clin Biol Res; 1991; 367():135-9. PubMed ID: 1924423
    [No Abstract]   [Full Text] [Related]  

  • 2. Human monoclonal antibodies in sepsis.
    de Koning J; Westendorp RG
    Neth J Med; 1991 Oct; 39(3-4):129-30. PubMed ID: 1791872
    [No Abstract]   [Full Text] [Related]  

  • 3. New immunotherapies for sepsis.
    Young LS; Wenzel RP
    Proc Assoc Am Physicians; 1995 Oct; 107(3):361-4. PubMed ID: 8608423
    [No Abstract]   [Full Text] [Related]  

  • 4. Life-saving immunotherapy with cross-reactive monoclonal antibodies against endotoxin: a critical evaluation of experimental and clinical studies.
    Cornelissen JJ; Schellekens JF; Kraaijeveld CA; Verhoef J
    Neth J Med; 1991 Oct; 39(3-4):170-6. PubMed ID: 1791879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on monoclonal antibody therapy in the gram-negative sepsis syndrome.
    Hecker RB
    J Am Osteopath Assoc; 1992 Aug; 92(8):1017-20. PubMed ID: 1429060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy of severe gram-negative bacterial infections. Centoxin: a new drug under monitoring. National Committee for the Evaluation of Centoxin].
    Pathol Biol (Paris); 1992 Dec; 40(10):975-6. PubMed ID: 1299810
    [No Abstract]   [Full Text] [Related]  

  • 7. Pilot study of anti-lipopolysaccharide human monoclonal antibody MAB-T88 in patients with gram-negative sepsis.
    Daifuku R; Panacek EA; Haenftling K; Swenson WK; Prescott AW; Johnson JL
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):36-9. PubMed ID: 8431557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy with antibodies to core lipopolysaccharide: a critical appraisal.
    Baumgartner JD
    Infect Dis Clin North Am; 1991 Dec; 5(4):915-27. PubMed ID: 1723740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches to the treatment of sepsis: lessons learned and future directions.
    Cross A
    Shock; 1996; 6 Suppl 1():S71-4. PubMed ID: 8828101
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapies for sepsis. Emerging therapies for sepsis and septic shock.
    Abraham E
    West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel immunotherapeutic approaches to the treatment of infections caused by Gram-negative bacteria.
    Palliyil S; Broadbent ID
    Curr Opin Pharmacol; 2009 Oct; 9(5):566-70. PubMed ID: 19726227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies for gram-negative sepsis.
    Med Lett Drugs Ther; 1991 Nov; 33(856):103-4. PubMed ID: 1943976
    [No Abstract]   [Full Text] [Related]  

  • 13. [Introduction of immunotherapeutic agents in clinical practice; current status concerning anti-endotoxin antibody HA-1A in the control of sepsis].
    van Deventer SJ; van der Linden CJ; Roord JJ; Schellekens H; Schellekens JF
    Ned Tijdschr Geneeskd; 1993 Feb; 137(7):334-6. PubMed ID: 8437630
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoclonal antibodies to endotoxin in the management of sepsis.
    Fang KC
    West J Med; 1993 Apr; 158(4):393-9. PubMed ID: 8317126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Septomonab (Centoxin) in the treatment of gram-negative septicemia].
    Fomsgaard A
    Ugeskr Laeger; 1993 Apr; 155(14):1066-71. PubMed ID: 8497944
    [No Abstract]   [Full Text] [Related]  

  • 16. [Monoclonal antibodies in the treatment of sepsis caused by Gram-negative microorganisms].
    Otero AJ; Linares M
    Rev Cubana Med Trop; 1998; 50(1):31-5. PubMed ID: 9842265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of endotoxemia and septicemia.
    Baumgartner JD; Glauser MP
    Immunobiology; 1993 Apr; 187(3-5):464-77. PubMed ID: 8330909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gram-negative bacterial sepsis in hospitals in the United States--natural history in the 1980s.
    Martin MA; Wenzel RP; Gorelick KJ
    Prog Clin Biol Res; 1991; 367():111-9. PubMed ID: 1924421
    [No Abstract]   [Full Text] [Related]  

  • 20. Projected impact of monoclonal anti-endotoxin antibody therapy.
    Bates DW; Lee TH
    Arch Intern Med; 1994 Jun; 154(11):1241-9. PubMed ID: 8203991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.